VANCOUVER, B.C. — ME Therapeutics Holdings Inc. (“ME Therapeutics” or the “Company”) a publicly listed biotechnology company discovering and developing novel cancer fighting drugs in the field of immuno-oncology, announced… Read More
17 abstracts from across the Company’s portfolio and pipeline highlight new clinical and real-world data on major depressive disorder and treatment-resistant depression New post-hoc analysis of CAPLYTA® (lumateperone) Phase 3 data… Read More
Vancouver, BC and Cincinnati, OH — A newly published study in Cognitive Behaviour Therapy has found that eSense™, a digital therapy platform for women’s sexual health, is effective in treating Sexual Interest/Arousal Disorder (SIAD)… Read More
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company), a leading global medical technology company, announced a major milestone for the In Celebration of Her™ program. Since its launch in 2014,… Read More
FRANKLIN LAKES, N.J. BD (Becton, Dickinson and Company) , a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic… Read More
